Le Lézard
Classified in: Health
Subject: FDA

Shoulder Innovations Announces FDA 510(k) Clearance For InSettm Reverse Shoulder Platform Technology


HOLLAND, Mich., Aug. 23, 2021 /PRNewswire/ -- Shoulder Innovations Inc, a leading innovator in the development of shoulder replacement systems, announced today that they have received FDA clearance for their InSettm Reverse Shoulder Arthroplasty System.

The InSettm Reverse Shoulder system seamlessly integrates and rounds out a best in class product line for shoulder arthroplasty including:

David Blue, Chief Commercialization Officer for Shoulder Innovations, said, "Our surgeon customers value having all possible shoulder surgery implants and instruments available in one tray.  Not only does our system provide a reduced implant and instrument footprint, but more importantly, the surgeon has access to our primary total shoulder and reverse shoulder including our innovative primary InSettm and InSettm Plus glenoid technology all in one place. This convertible system is game-changing and efficient.  The InSettm Platform simplifies shoulder replacement technology in order to improve outcomes."

Matt Ahearn, Chief Operating Officer for Shoulder Innovations, said, "Shoulder Innovations has been preparing for this product release for many months. The FDA clearance and upcoming launch of the InSettm Reverse Shoulder represent a significant inflection point for all aspects of the Shoulder Innovations business.  Early indications of customer demand for this technology have been very high, and we're ready to deliver this unique product to our clinical partners to enable excellent patient care."

Brandon Florence, Director of Education & Product Management added, "The InSettm Reverse Shoulder system continues to follow the "Simple, Yet Significant" approach as is seen with our proven InSettm Total Shoulder System. This approach gives our surgeon customers a dynamic range of surgical options to help deliver better outcomes to their patients in an efficient manner.  It is a truly convertible platform system that won't overstuff the joint.  Having this entire SI shoulder system all interact and work seamlessly with our latest and most innovative 3-D PreView Software Planning System, makes this complete shoulder system even that much more compelling."

Rob Ball, CEO of Shoulder Innovations said, "Our team is very excited to bring the Reverse system to market. While it indeed provides for game-changing simplicity, it simultaneously resolves many significant technical and clinical challenges faced by orthopedic specialists seeking to offer optimal outcomes to their patients.  We've been able to package not 2, but 6 products in one instrument tray, an unmatched efficiency in the marketplace. This includes all options necessary to treat glenoid deformity from simple to complex. This comes with published long-term proof of excellent outcomes for our InSet technology. Our humeral fixation is unmatched and offers the simplest technique on the market. Our technical team working with our clinical team has assembled a truly special solution, and together with our recent equity financing, Shoulder Innovations is very well positioned to bring value for all stakeholders in the care event."

The Reverse Shoulder was developed in conjunction with a team of specialist trained shoulder surgeons and will begin surgical cases in the coming days.

Additional information about Shoulder Innovations and its Total Shoulder Replacement System is available at https://shoulderinnovations.com

About Shoulder Innovations:

Shoulder Innovations, LLC is a medical device development company that designs and commercializes innovative products which demonstrate the potential for improved patient care and reduced overall cost to the healthcare system.  

Leveraging its breakthrough, patented, inset glenoid design, Shoulder Innovations is commercializing a shoulder replacement implant system focused on improving outcomes related to the greatest cause of shoulder replacement failure: glenoid loosening.  

The InSettm technology has been shown in testing to significantly reduce glenoid implant micro-motion and simplifies surgical the surgical technique, potentially reducing complications or increase implant longevity.

Shoulder Innovations is based in Holland, Mich.  

Learn more about Shoulder Innovations and its Total Shoulder Replacement System at shoulderinnovations.com.

SOURCE Shoulder Innovations


These press releases may also interest you

at 20:00
Helix BioPharma Corp. ("Helix" or the "Company"), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, announced today that it anticipates the filing of its annual financial...

at 19:59
The Centers for Medicare and Medicaid Services (CMS) released its annual quality rankings. For the 2022 plan year, Network Health earned a 5 out of 5-Star Rating from CMS for its Medicare Advantage PPO plans. This is Medicare's highest possible...

at 19:21
Boehringer Ingelheim today announced the U.S. Food and Drug Administration (FDA) approved the supplemental Biologics License Application (sBLA) for Cyltezo® (adalimumab-adbm) as the first Interchangeable biosimilar with Humira® (adalimumab). The FDA...

at 19:20
Novartis Pharmaceuticals Canada Inc. applauds the government of Quebec's decision to provide public reimbursement for Zolgensma® (onasemnogene abeparvovec)...

at 18:20
Worcester Polytechnic Institute (WPI) researcher Loris Fichera has developed a flexible, slimmed-down robotic laser probe for endoscopic larynx surgeries that could reduce recovery time for patients and cut health care spending by shifting procedures...

at 18:15
The "Global Industrial Radiography Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Technique (Film-based Radiography and Digital Radiography); End-User Industry" report has been added to ResearchAndMarkets.com's offering. The...



News published on 23 august 2021 at 06:47 and distributed by: